3 startups join Houston cleantech incubator

just joined

Halliburton Labs has announced its next set of clean energy tech companies. Photo courtesy of Halliburton

Three businesses have just joined Halliburton Labs, a Houston-based accelerator for clean energy startups.

The new members of Halliburton Labs are A-W Energy, a Finland-based startup whose technology converts ocean waves into energy; RedShift Energy, a Pennsylvania-based startup whose technology recovers hydrogen; and Renkube, an India-based startup whose technology aims to lower the cost of producing solar power.

Halliburton Labs says its participants enjoy access to technical expertise, mentorships, and other benefits.

“These new companies reflect our view that numerous innovations at scale are important in the evolution of energy systems. … We are eager to collaborate with these companies to help them achieve their strategic, operational, and financial milestones,” Dale Winger, managing director of Halliburton Labs, says in a news release.

Halliburton, a provider of energy equipment and services, launched Halliburton Labs in 2020. The accelerator, a wholly owned subsidiary of Houston-based Halliburton, is now sifting through applications for its next group of startups. Finalists will make presentations September 28 at a Halliburton Labs pitch day.

Here are details about the three new startups at Halliburton Labs.

AW-Energy

AW-Energy’s WaveRoller technology harnesses kinetic energy from ocean waves to generate electricity.

“With the technology already certified and deployed at commercial scale, we are excited to access Halliburton’s global network and engineering expertise to develop our first series of wave farms,” says Christopher Ridgewell, CEO of AW-Energy.

RedShift Energy

RedShift Energy uses plasma energy to produce hydrogen from hydrogen sulfide. For instance, its technology unlocks trapped reserves downstream and recycles hydrogen upstream.

“Joining Halliburton Labs will accelerate commercialization with the help of their broad expertise, supply chain experience, and worldwide network,” says Alex Gutsol, co-founder and chief scientist of RedShift Energy.


Renkube

Renkube developed a glass designed to harvest light in an effort to lower the cost of generating solar energy. The patent-pending glass is used on solar panels to track sunlight.

“We intend to leverage Halliburton’s deep industrial expertise in manufacturing and operations as we roll out our product for commercialization,” says Balaji Lakshmikanth Bangolae, founder and CEO of Renkube.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.